
Customer Care Tel: 0161 483 5884
Email: ukcustomer@alere.com
Website: www.alere.co.uk
Our goal is to ensure the appropriate use of diagnostics to deliver improved health outcomes, better patient experiences and more cost effective care pathways.
Early identification and management of patients with high cardiovascular risk factors can lead to improved quality of life, lower mortality and reduced costs.
The Alere cardiovascular portfolio includes diagnostic tests measuring biomarkers in a variety of point-of-care settings including the hospital emergency setting or bedside, outpatient office, GP surgery or patient home, spanning the disease continuum from risk assessment, diagnosis to ongoing monitoring.
Alere is focused in bringing testing closer to the clinician and the patient, enabling better information, earlier intervention and more cost effective disease management.
At the 2011 Biomedical Science Congress Alere conducted market research and surveyed over 700 laboratory based scientists.
Alere is working with the NHS and specialist providers to implement new and improved care pathways to bring care closer to the patient. With...
Alere actively connects diagnostics and health management solutions, giving medical professionals and consumers the tools they need to make more...
Thank you for taking the guided tour around the Alere Art Gallery at BSH 2010.
The first training sessions began in Bristol PCT on Friday May 14th with 12 practices participating along with Sarah Hollington (Bristol PCT...
With our well-proven point of care LDX lipid analyser, we have been at the forefront in helping to deliver the Department of Health's 'NHS Health...
Acute Kidney Injury (AKI) is a serious medical challenge. The condition, which affects as many as 25% - 50% of ICU patients, is very difficult...
Welcome to the first issue of the Alere magazine.